Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.188NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.38.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N/ANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.42.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.348NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.459NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.415.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.98NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.566NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.480NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.579NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.11 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.435NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.445NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.124NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.384NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.569NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.524NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.596.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.473NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.595.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.76.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.38.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.494NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.167NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.165NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.554NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2.5.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.450NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.130NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.268NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used